Clinical Application of AI-assisted Ultrasound Technology in the Preoperative Evaluation of Thyroid Cancer

Launched by FUJIAN MEDICAL UNIVERSITY · Jul 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of advanced ultrasound technology, supported by artificial intelligence (AI), to improve the way doctors evaluate thyroid cancer before surgery. The goal is to see if this AI-assisted method can more accurately detect and diagnose thyroid nodules and lymph nodes compared to traditional ultrasound images. If the results from the AI and the standard ultrasound differ, doctors will perform a biopsy (a small tissue sample) to confirm the diagnosis. By comparing these findings to the final pathology results after surgery, researchers hope to establish a more reliable way to assess thyroid cancer, which could help doctors make better treatment decisions.

To participate in this trial, patients must have a confirmed diagnosis of thyroid cancer or benign thyroid tumors that require surgery. They should also have high-quality ultrasound images and be willing to consent to the study. However, individuals with a history of neck surgery, certain other cancers, thyroid dysfunction, or who have poor-quality ultrasound images will not be eligible. Participants can expect to undergo the usual preoperative evaluations, with the added benefit of AI technology being used to enhance their diagnosis. This study is currently recruiting participants of all ages and genders, aiming to improve patient care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with preoperative pathological confirmation of thyroid malignant tumors undergoing surgical treatment.
• • Patients with benign thyroid tumors, such as thyroid adenomas causing compressive symptoms, undergoing surgical treatment.
• • Patients with complete and high-quality traditional two-dimensional color ultrasound images.
• • Complete postoperative pathology reports.
• • Willingness to participate in this clinical trial and signing of informed consent.
• Exclusion Criteria:
• • Patients with a history of neck surgery or radiotherapy.
• • Patients with a history of malignant tumors in other parts of the body.
• • Patients with thyroid dysfunction.
• • Incomplete or poor-quality traditional two-dimensional color ultrasound images.
• • Incomplete postoperative pathology reports.
• • Refusal to participate in this clinical trial.